PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer	Adnexal Diseases, Carcinoma, Endometrioid, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, mismatch repair cancer syndrome 1, neoplasm, ovarian cancer, ovarian disorder, uterine disorder	Recruiting	Not applicable	2026-08-10		NCT06549855

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Chao Yang Hospital	88
Huazhong University of Science and Technology	83
Peking Union Medical College Hospital	417
Peking University People's Hospital	269
Peking University Third Hospital	243
Shandong University	50
Shengjing Hospital	111
Tianjin Medical University	35

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University People's Hospital	Beijing	China	146